Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-23-009504

Options or other derivatives

  • Chief Medical Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Agah Ramtin Chief Medical Officer 2023-03-15 Grant or award · Employee Stock Option (right to buy) +65,000 65,000 D
Loading xslF345X04/ownership.xml…